Drug Development Solutions

About DDS

Drug Development Solutions (DDS) helps develop new medicines and products to improve the quality of life.

We are a contract research organisation (CRO) part of Alliance Pharma, Inc. The services in our dedicated global laboratories span the entire lifecycle of product development and commercialisation and can be adapted to suit small local trials or large global programmes. We offer GLP and GCP bioanalysis of small molecules, large proteins for pharmacokinetics, biomarkers and immunogenicity. In addition, we also provide cGMP analytical sciences research and testing services, consultancy and quality control solutions to support Chemistry, Manufacturing, and Controls (CMC) requirements at all stages of the drug development pipeline from discovery through preclinical and clinical development to commercial manufacture.

Within one of the world's largest bioanalytical labs, our bioanalytical services CRO provide support from early discovery to late phase clinical trials. Bioanalytical Solutions include liquid-chromatography mass spectrometry (LC-MS) and immunoassay bioanalysis, to provide data for pharmacokinetics, immunogenicity, pharmacodynamics and cell-based assays supporting all phases of drug development to GCP and GLP standards.

From our UK-based cGMP labs, our scientists provide a consultative, flexible and dependable solution for the development, validation, and application of testing methods. Our Analytical Materials Science Solutions provides specialist testing of raw materials, formulated products, packaging and medical devices for trace impurities, contamination, degradation and quality control to support CMC (Chemistry Control and Manufacture) analytical testing to GMP (Good Manufacturing Practice) standard.